Etodolac has been on the market for 39 years globally since its medical use approval in 1985, and for 33 years in the U.S. since its approval in 1991.
Understanding Etodolac's Market Journey
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used to manage pain and inflammation. Its journey to market involved several key milestones:
- 1971: Etodolac was first patented.
- 1985: It received its initial approval for medical use, making it available on the global market.
- 1991: It gained approval for use in the United States.
This dual timeline means that while the drug has been in use internationally since the mid-1980s, its presence in the U.S. market began a few years later.
Market Presence Timeline
To clarify the duration Etodolac has been available, consider the following timeline based on its approval dates:
| Milestone | Year Approved | Duration (as of 2024) |
|---|---|---|
| Global Medical Use | 1985 | 39 years |
| U.S. Medical Use | 1991 | 33 years |
What is Etodolac Used For?
As an NSAID, Etodolac is prescribed to alleviate symptoms associated with various conditions, including:
- Osteoarthritis: Reducing joint pain and stiffness.
- Rheumatoid Arthritis: Managing inflammation and pain in affected joints.
- Acute Pain: Providing relief from various types of short-term pain, such as post-surgical pain or dental pain.
Its long presence on the market highlights its established role in pain and inflammation management. For more detailed information on Etodolac, you can consult reliable sources such as its entry on Wikipedia.
